Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

UNIVERSAL HEALTH SVCS ($UHS) Releases Q1 2026 Earnings

None

UNIVERSAL HEALTH SVCS ($UHS) posted quarterly earnings results for Q1 2026 on Monday, April 27th. The company reported earnings of $5.62 per share, beating estimates of $5.46 by $0.16. The company also reported revenue of $4,495,180,000, beating estimates of $4,431,414,965 by $63,765,035.

You can see Quiver Quantitative's $UHS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

EARLY ACCESS
Receive UHS Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

UNIVERSAL HEALTH SVCS Insider Trading Activity

UHS Insider Trades

UNIVERSAL HEALTH SVCS insiders have traded $UHS stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $UHS stock by insiders over the last 6 months:

  • WARREN J. NIMETZ has made 0 purchases and 2 sales selling 3,817 shares for an estimated $852,343.
  • ELLIOT J MD MBA SUSSMAN has made 0 purchases and 3 sales selling 1,639 shares for an estimated $345,897.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

UNIVERSAL HEALTH SVCS Hedge Fund Activity

We have seen 327 institutional investors add shares of UNIVERSAL HEALTH SVCS stock to their portfolio, and 296 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

UNIVERSAL HEALTH SVCS Analyst Ratings

Wall Street analysts have issued reports on $UHS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Wells Fargo issued a "Overweight" rating on 11/13/2025

To track analyst ratings and price targets for UNIVERSAL HEALTH SVCS, check out Quiver Quantitative's $UHS forecast page.

UNIVERSAL HEALTH SVCS Price Targets

Multiple analysts have issued price targets for $UHS recently. We have seen 6 analysts offer price targets for $UHS in the last 6 months, with a median target of $238.0.

Here are some recent targets:

  • Stephen Baxter from Wells Fargo set a target price of $212.0 on 03/02/2026
  • Sarah James from Cantor Fitzgerald set a target price of $229.0 on 02/27/2026
  • Andrew Mok from Barclays set a target price of $268.0 on 02/26/2026
  • Ryan Langston from TD Cowen set a target price of $245.0 on 01/07/2026
  • Jason Cassorla from Guggenheim set a target price of $274.0 on 12/02/2025
  • Ben Hendrix from RBC Capital set a target price of $231.0 on 10/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles